![Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants - ScienceDirect Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962210007632-gr1.jpg)
Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants - ScienceDirect
![Possible mechanisms of action of propranolol in infantile hemangiomas... | Download Scientific Diagram Possible mechanisms of action of propranolol in infantile hemangiomas... | Download Scientific Diagram](https://www.researchgate.net/profile/Ingo-Daehnert/publication/236225663/figure/fig1/AS:203006252458001@1425411870713/Possible-mechanisms-of-action-of-propranolol-in-infantile-hemangiomas-IHs-In-the_Q320.jpg)
Possible mechanisms of action of propranolol in infantile hemangiomas... | Download Scientific Diagram
![Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis | Pediatric Research Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis | Pediatric Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpr.2013.231/MediaObjects/41390_2014_Article_BFpr2013231_Fig7_HTML.jpg)
Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis | Pediatric Research
![Pingyangmycin stimulates apoptosis in human hemangioma‑derived endothelial cells through activation of the p53 pathway Pingyangmycin stimulates apoptosis in human hemangioma‑derived endothelial cells through activation of the p53 pathway](https://www.spandidos-publications.com/article_images/mmr/10/1/MMR-10-01-0301-g01.jpg)
Pingyangmycin stimulates apoptosis in human hemangioma‑derived endothelial cells through activation of the p53 pathway
![β-adrenergic receptor-dependent and -independent effects of propranolol in infantile hemangioma | Semantic Scholar β-adrenergic receptor-dependent and -independent effects of propranolol in infantile hemangioma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/63994b769f5605779fe9e7f7df1a9629c0ac16b7/19-Figure1-1.png)
β-adrenergic receptor-dependent and -independent effects of propranolol in infantile hemangioma | Semantic Scholar
![JCI - Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma JCI - Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma](https://dm5migu4zj3pb.cloudfront.net/manuscripts/151000/151109/medium/JCI151109.ga.jpg)
JCI - Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma
![Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate | SpringerLink Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12070-018-1410-8/MediaObjects/12070_2018_1410_Fig1_HTML.png)
Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate | SpringerLink
![Propranolol exhibits activity against hemangiomas independent of beta blockade | npj Precision Oncology Propranolol exhibits activity against hemangiomas independent of beta blockade | npj Precision Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41698-019-0099-9/MediaObjects/41698_2019_99_Fig9_HTML.png)
Propranolol exhibits activity against hemangiomas independent of beta blockade | npj Precision Oncology
![Infantile hemangioma: pathogenesis and mechanisms of action of propranolol - Rotter - 2017 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library Infantile hemangioma: pathogenesis and mechanisms of action of propranolol - Rotter - 2017 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/eb03f39c-8d9d-40eb-81f1-095e33bcec34/ddg.2017.15.issue-12.cover.jpg)
Infantile hemangioma: pathogenesis and mechanisms of action of propranolol - Rotter - 2017 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library
![Frontiers | Central Effects of Beta-Blockers May Be Due to Nitric Oxide and Hydrogen Peroxide Release Independently of Their Ability to Cross the Blood-Brain Barrier Frontiers | Central Effects of Beta-Blockers May Be Due to Nitric Oxide and Hydrogen Peroxide Release Independently of Their Ability to Cross the Blood-Brain Barrier](https://www.frontiersin.org/files/Articles/435540/fnins-13-00033-HTML/image_m/fnins-13-00033-g001.jpg)
Frontiers | Central Effects of Beta-Blockers May Be Due to Nitric Oxide and Hydrogen Peroxide Release Independently of Their Ability to Cross the Blood-Brain Barrier
![Propranolol inhibits the proliferation, migration and tube formation of hemangioma cells through HIF-1α dependent mechanisms – ScienceOpen Propranolol inhibits the proliferation, migration and tube formation of hemangioma cells through HIF-1α dependent mechanisms – ScienceOpen](https://www.scienceopen.com/document_file/259bfaf9-f5c4-4a79-a86d-fecbb5c3b9bf/PubMedCentral/large.png)
Propranolol inhibits the proliferation, migration and tube formation of hemangioma cells through HIF-1α dependent mechanisms – ScienceOpen
![Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations | Actas Dermo-Sifiliográficas Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations | Actas Dermo-Sifiliográficas](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1578219012000315:gr3.jpeg?xkr=ue/ImdikoIMrsJoerZ+w91sAmkCw32Jed9sZf6jzEuDbFpW7G0NfARZs8afh+9K8v8RN+oFy2ZmalFHXVYo6Akdb5dOYTvnAx3pNEJrQCCIhIazXPPa2g0UVu+AjbF9kRcGM5sLb1X911Ef9TMVc5cyQfJfY+9CwmVkskVu2+YWltG8Lz6Vc1w4T9ym4MX6yBG9t1/ZXUPbBdJMmaVjFAsRKQJ9EAdmJSwVU2hY/YR9QHP5FB91UUmHbCj5KKqKZLuOL9zeqEL7EOQg6GlhIgW0vyghdW9ZUgKQhx70Oy8w=)
Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations | Actas Dermo-Sifiliográficas
![Frontiers | Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas Frontiers | Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas](https://www.frontiersin.org/files/Articles/427848/fonc-08-00605-HTML/image_m/fonc-08-00605-g001.jpg)
Frontiers | Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas
![Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration | Scientific Reports Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-60025-2/MediaObjects/41598_2020_60025_Fig1_HTML.png)
Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration | Scientific Reports
![The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action - Ji - 2015 - British Journal of Dermatology - Wiley Online Library The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action - Ji - 2015 - British Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/de3a32a0-3d0c-4f72-a032-58f0f1996030/bjd13388-fig-0004-m.jpg)